Contemporary scientific insights: role of biomarkers of inflammation in cardiovascular disease/atherosclerosis.

Contemporary scientific insights: role of biomarkers of inflammation in cardiovascular disease/atherosclerosis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Contemporary scientific insights: role of biomarkers of inflammation in cardiovascular disease/atherosclerosis. Abstract Text:

Contemporary scientific insights: role of biomarkers of inflammation in cardiovascular disease/atherosclerosis. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Contemporary scientific insights: role of biomarkers of inflammation in cardiovascular disease/atherosclerosis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Critical pathways in cardiology

VOLUME: 5

Page Numbers: 191-210

Journal Abbreviation:

ISSN: 1535-2811

DAY: 14

MONTH: Dec

YEAR: 2006

Contemporary scientific insights: role of biomarkers of inflammation in cardiovascular disease/atherosclerosis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101165286

Contemporary scientific insights: role of biomarkers of inflammation in cardiovascular disease/atherosclerosis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Contemporary scientific insights: role of biomarkers of inflammation in cardiovascular disease/atherosclerosis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Contemporary scientific insights: role of biomarkers of inflammation in cardiovascular disease/atherosclerosis.

AFFILIATION: From the Robert E. Stowell Endowed Chair in Experimental Pathology Professor of Pathology and Internal Medicine Director, Laboratory for Atherosclerosis and Metabolic Research University of California, Davis Medical Center Davis, Davis, California.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Crit Pathw Cardiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Contemporary scientific insights: role of biomarkers of inflammation in cardiovascular disease/atherosclerosis Related Publications

• A dose-response study on the effects of purified lycopene supplementation on biomarkers of oxidative stress.
• Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop.
• C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling.
• CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers.
• Contemporary scientific insights: role of biomarkers of inflammation in cardiovascular disease/atherosclerosis.
• Detection by immunofixation of M proteins in hypogammaglobulinemic patients with normal serum protein electrophoresis results.
• Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome.
• Editor's Perspective on Metabolic Syndrome for 2008.
• Editorial.
• Effect of high-dose {alpha}-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease.
• Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome.
• High-dose alpha-tocopherol therapy does not affect HDL subfractions in patients with coronary artery disease on statin therapy.
• High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome.
• Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats.
• Increased Toll-Like Receptor (TLR) 2 and TLR4 Expression in Monocytes from Patients with Type 1 Diabetes: Further Evidence of a Proinflammatory State.
• Oxidative stress and atherosclerosis.
• RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus.
• Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome.
• Simvastatin reduces circulating plasminogen activator inhibitor 1 activity in volunteers with the metabolic syndrome.
• Statins and biomarkers of inflammation.
• The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells.
• The effect of weight loss and dietary fatty acids on inflammation.
• Validation of the circulating monocyte being representative of the cholesterol-loaded macrophage: biomediator activity.